CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Norpharma's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 21, 2025
Patent NumberGrant DateTitleTotal Oppositions
May 1, 2013Sustained Analgesia Achieved With Transdermal Delivery Of Buprenorphine3

Top competitors of Norpharma

Top competitors of Norpharma based on patent oppositions.